Integral Diagnostics Valuation
| IDX Stock | 2.31 0.05 2.12% |
Based on Macroaxis valuation methodology, the firm appears to be overvalued. Integral Diagnostics retains a regular Real Value of USD2.08 per share. The prevalent price of the firm is USD2.31. Our model calculates the value of Integral Diagnostics from evaluating the firm fundamentals such as Current Valuation of 1.36 B, return on asset of 0.0257, and Return On Equity of 0.0114 as well as inspecting its technical indicators and probability of bankruptcy.
Price Book 1.2384 | Enterprise Value 1.4 B | Enterprise Value Ebitda 18.4091 | Price Sales 1.7169 | Forward PE 16.4474 |
Overvalued
Today
Please note that Integral Diagnostics' price fluctuation is risky at this time. Calculation of the real value of Integral Diagnostics is based on 3 months time horizon. Increasing Integral Diagnostics' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Integral Diagnostics' intrinsic value may or may not be the same as its current market price of 2.31, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 2.31 | Real 2.08 | Hype 2.39 |
The intrinsic value of Integral Diagnostics' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Integral Diagnostics' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Integral Diagnostics helps investors to forecast how Integral stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Integral Diagnostics more accurately as focusing exclusively on Integral Diagnostics' fundamentals will not take into account other important factors: Integral Diagnostics Cash |
|
Integral Diagnostics Total Value Analysis
Integral Diagnostics is currently anticipated to have takeover price of 1.36 B with market capitalization of 843.54 M, debt of 357.8 M, and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Integral Diagnostics fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
1.36 B | 843.54 M | 357.8 M |
Integral Diagnostics Investor Information
About 13.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 1.24. Some equities with similar Price to Book (P/B) outperform the market in the long run. Integral Diagnostics last dividend was issued on the 6th of March 2025. Based on the key indicators related to Integral Diagnostics' liquidity, profitability, solvency, and operating efficiency, Integral Diagnostics is not in a good financial situation at this time. It has a very high probability of going through financial hardship in April.| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Total Cash From Operating Activities | 79.9 M | 76.1 M |
|
| |||||
| Operating Income | 5.9 M | 6.2 M |
|
|
Integral Diagnostics Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Integral Diagnostics has an asset utilization ratio of 63.11 percent. This implies that the Company is making USD0.63 for each dollar of assets. An increasing asset utilization means that Integral Diagnostics is more efficient with each dollar of assets it utilizes for everyday operations.Integral Diagnostics Ownership Allocation
Integral Diagnostics has a total of 371.6 Million outstanding shares. Integral Diagnostics retains 13.2 (percent) of its outstanding shares held by insiders and 23.98 (percent) owned by outside corporations. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.Integral Diagnostics Profitability Analysis
The company reported the revenue of 469.7 M. Net Loss for the year was (60.7 M) with profit before overhead, payroll, taxes, and interest of 155.53 M.About Integral Diagnostics Valuation
The stock valuation mechanism determines Integral Diagnostics' current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Integral Diagnostics based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Integral Diagnostics. We calculate exposure to Integral Diagnostics's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Integral Diagnostics's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 513.8 M | 539.5 M |
Additional Tools for Integral Stock Analysis
When running Integral Diagnostics' price analysis, check to measure Integral Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Integral Diagnostics is operating at the current time. Most of Integral Diagnostics' value examination focuses on studying past and present price action to predict the probability of Integral Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Integral Diagnostics' price. Additionally, you may evaluate how the addition of Integral Diagnostics to your portfolios can decrease your overall portfolio volatility.